Klann et al. (2017). Nat. Biotechnol. CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
DOI: 10.1038/nbt.3853
Wright and Sanjana (2016). Trends Genet. CRISPR Screens to Discover Functional Noncoding Elements
DOI: 10.1016/j.tig.2016.06.004
Thakore et al. (2016). Nat. Methods. Editing the epigenome: technologies for programmable transcription and epigenetic modulation
DOI: 10.1038/nmeth.3733
Thakore et al. (2015). Nat. Methods. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
DOI: 10.1038/nmeth.3630
Romanoski et al. (2015). Trends Immunol. Exploiting genomics and natural genetic variation to decode macrophage enhancers
DOI: 10.1016/j.it.2015.07.006
Köferle et al. (2015). Genome Med. Brave new epigenomes: the dawn of epigenetic engineering
DOI: 10.1186/s13073-015-0185-8
Hilton et al. (2015). Nat. Biotechnol. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
DOI: 10.1038/nbt.3199
Konermann et al. (2014). Nature. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
DOI: 10.1038/nature14136
Gilbert et al. (2014). Cell. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
DOI: 10.1016/j.cell.2014.09.029
Heller et al. (2014). Nat. Neurosci. Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors
DOI: 10.1038/nn.3871
Lam et al. (2014). Trends Biochem. Sci. Enhancer RNAs and regulated transcriptional programs
DOI: 10.1016/j.tibs.2014.02.007
Voigt and Reinberg (2013). Nat. Biotechnol. Epigenome editing
DOI: 10.1038/nbt.2756
Maeder et al. (2013). Nat. Biotechnol. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins
DOI: 10.1038/nbt.2726
Mendenhall et al. (2013). Nat. Biotechnol. Locus-specific editing of histone modifications at endogenous enhancers
DOI: 10.1038/nbt.2701